In New Zealand between 2014 and 2017, 9,093 patients were diagnosed with lung and tracheal malignancy. At a regional level, the Southern District Health Board (SDHB) has a catchment of over 350,000 patients, covering the Otago and Southland regions.
Most patients with lung cancer present with advanced disease and are offered palliative treatment. Approximately 20% of New Zealand patients with newly diagnosed lung cancer are treated surgically.
We present the case of a 76-year-old woman who developed symptomatic hypercalcaemia following the insertion of CSBs for a periprosthetic joint infection.
Papillary thyroid cancer (PTC) is the most common type of well differentiated thyroid cancer. Thyroid cancer affects over 300 individuals in New Zealand every year with an incidence of 5.2 per 100,000 population.
In the last decade of last century and in the first of this the great development of operative surgery drew the surgeon’s attention from the treatment of fractures.